[
  {
    "ts": "2025-08-06T11:00:00+00:00",
    "headline": "Compugen Reports Second Quarter 2025 Results",
    "summary": "Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the second quarter of 2025 and provided a corporate update.",
    "url": "https://finance.yahoo.com/news/compugen-reports-second-quarter-2025-110000056.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b61cf4c0-08b6-32f6-ba06-4493e2a49942",
      "content": {
        "id": "b61cf4c0-08b6-32f6-ba06-4493e2a49942",
        "contentType": "STORY",
        "title": "Compugen Reports Second Quarter 2025 Results",
        "description": "",
        "summary": "Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today reported financial results for the second quarter of 2025 and provided a corporate update.",
        "pubDate": "2025-08-06T11:00:00Z",
        "displayTime": "2025-08-06T11:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/compugen-reports-second-quarter-2025-110000056.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/compugen-reports-second-quarter-2025-110000056.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CGEN"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "AZN.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-06T03:12:02+00:00",
    "headline": "Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings",
    "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.",
    "url": "https://finance.yahoo.com/news/gilead-sciences-gild-reports-q2-031202278.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "79cac825-06c2-3692-8feb-db11b8ae9619",
      "content": {
        "id": "79cac825-06c2-3692-8feb-db11b8ae9619",
        "contentType": "STORY",
        "title": "Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of Earnings",
        "description": "",
        "summary": "Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s what investors should know.",
        "pubDate": "2025-08-06T03:12:02Z",
        "displayTime": "2025-08-06T03:12:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GILD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7IhZSScYZ4CvnQJJpve_Dg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cv.0mSrHV7hG2Zeh2xc10A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-reports-q2-031202278.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-gild-reports-q2-031202278.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]